Is Li Gan Pharmaceutical a Fortune 500 company?

Li Gan Pharmaceutical is not a Fortune 500 company. Li Gan Pharmaceutical Co., Ltd., founded in 1998, is a high-tech biopharmaceutical enterprise integrating scientific research, development, production and sales. The company is in a leading position at home and abroad in the development, research and production of biosynthetic human insulin and its analogues, and is a professional company specializing in biosynthetic human insulin analogues. As a well-known insulin production and research enterprise in China, Li Gan Pharmaceutical has a very good development prospect. Compared with foreign companies, Li Gan's third-generation insulin is naturally more cost-effective, and its market share is steadily increasing. Most importantly, while the market share is increasing, the whole market share is also expanding rapidly. In 20 18, the sales scale of insulin glargine in public medical institutions in China reached 5.273 billion, and CAGR 19 was realized from 20 13 to 20 18.